MetaCap

Cardinal Health (CAH) vs EnerSyn Global (ESYN)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Cardinal Health (CAH) has outperformed EnerSyn Global (ESYN) over the past year, gaining 30.2% versus a loss of 26.5%. Cardinal Health is the larger company by market cap ($63.06 billion vs $37.4 million), about 1684.4 times the size. Cardinal Health pays a dividend yielding 0.75%, while EnerSyn Global does not currently pay one.

Cardinal Health converts more of its revenue into profit, with a net margin of 0.7% versus -303.4%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CAH+30.23%ESYN-26.49%
+83%+19%-45%
Nov 21, 20251 yearNov 20, 2026
CAH+370.69%ESYN-97.73%
+409%+144%-122%
Mar 21, 20225 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CAH versus ESYN key metrics
MetricCAHESYN
Share price$272.81$1.11
Market cap$63.06B$37.44M
1-day change+0.17%-0.89%
YTD return+32.75%-25.50%
1-year return+30.23%-26.49%
5-year return+473.13%—
P/E ratio (TTM)35.29—
Forward P/E18.89—
EPS (TTM)$7.73$-0.58
Dividend yield0.75%0.00%
Annual dividend$2.05$0.00
Revenue (latest FY)$254.25B$866.93K
Revenue growth (YoY)+14.23%-30.84%
Net income (latest FY)$1.71B$-2.63M
Gross margin3.84%53.03%
Operating margin1.03%—
Net margin0.67%-303.44%
52-week high$286.29$2.81
52-week low$180.45$0.88
Distance from 52-week high-4.71%-60.50%
Analyst consensusbuy—
Avg. price target upside+8.09%—
Average volume1.72M38.17K
Shares outstanding231.14M33.73M
Employees58,7884
SectorHealth CareHealth Care
IndustryOther PharmaceuticalsOther Pharmaceuticals

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Cardinal Health is about 1684.4 times larger than EnerSyn Global by market value ($63.06B vs $37.44M).
  • CAH has outperformed ESYN by 56.7 percentage points over the past year.
  • Cardinal Health is more profitable, keeping 0.7 cents of every revenue dollar as net income versus -303.4 cents for EnerSyn Global.
  • Cardinal Health grew revenue faster in its latest fiscal year (+14.23% vs -30.84%).

About Cardinal Health

CAH stock →

Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally.

Health Care · Other Pharmaceuticals · 58,788 employees

About EnerSyn Global

ESYN stock →

EnerSyn Global Inc. engages in the food and beverage business in Singapore and South Korea.

Health Care · Other Pharmaceuticals · 4 employees

CAH vs ESYN FAQ

Which is bigger, Cardinal Health or EnerSyn Global?

Cardinal Health (CAH) is larger, with a market capitalization of $63.06B compared with $37.44M for EnerSyn Global (ESYN).

Which stock has performed better over the past year, CAH or ESYN?

CAH returned +30.23% over the past 12 months, compared with -26.49% for ESYN (price return, excluding dividends). Past performance does not predict future results.

Which pays a higher dividend, Cardinal Health or EnerSyn Global?

Cardinal Health pays a dividend yielding 0.75%, while EnerSyn Global does not currently pay a regular dividend.

Are Cardinal Health and EnerSyn Global in the same industry?

Yes. Both are classified in the Other Pharmaceuticals industry within the Health Care sector.

More comparisons